Hojo Sachiko, Ishikawa Satoshi, Kumano Hiroaki, Miyata Mikio, Sakabe Kou
Department of Environmental Science, Shokei Gakuin University, 4-10-1 Yurigaoka, Natori-shi, Miyagi 981-1295, Japan.
Int J Hyg Environ Health. 2008 Oct;211(5-6):682-9. doi: 10.1016/j.ijheh.2007.09.007. Epub 2007 Dec 21.
Multiple chemical sensitivity (MCS), a syndrome in which multiple symptoms occur with low-level chemical exposure, has not been clarified in detail. The aim of our study was to clarify the clinical characteristics of physician-diagnosed MCS patients in Japan. We analyzed patient characteristics based on the medical records of 106 patients diagnosed with MCS according to the 1999 Consensus and the Japanese diagnostic criteria for MCS. We evaluated subjective symptoms using the Quick Environment Exposure Sensitivity Inventory (QEESI) and compared the QEESI scores with those of four MCS patient groups in the US reported by Miller and Prihoda [Miller, C.S., Prihoda, T.J., 1999b. A controlled comparison of symptoms and chemical intolerances reported by Gulf War veterans, implant recipients, and persons with multiple chemical sensitivity. Toxicol Ind Health 15, 386-397]. Female patients accounted for 74.0%. Most male patients were in their 30s, whereas female ages ranged widely from 10 to 65 years. Among estimated onset factors, those seen in males tended to be workplace related, while female patients showed a variety of factors. Co-morbid allergic disease was present in 84.0% of patients. A significant difference in the QEESI score between male and female patients was found in only one item out of 10 in symptom severity and life impact. However, all 10 items in chemical intolerance were significantly higher in females than in males. The mean QEESI score in the patient group in our study was lower than those in any of the four self-reported patient groups in the US.
多重化学物质敏感症(MCS)是一种在低水平化学物质暴露时出现多种症状的综合征,其具体情况尚未完全阐明。我们研究的目的是明确日本医生诊断的MCS患者的临床特征。我们根据1999年共识和日本MCS诊断标准,对106例被诊断为MCS的患者的病历进行分析,以此来分析患者特征。我们使用快速环境暴露敏感量表(QEESI)评估主观症状,并将QEESI评分与Miller和Prihoda报告的美国四个MCS患者组的评分进行比较[Miller, C.S., Prihoda, T.J., 1999b. 海湾战争退伍军人、植入物接受者和多重化学物质敏感者报告的症状和化学不耐受的对照比较。毒理学与工业卫生15, 386 - 397]。女性患者占74.0%。大多数男性患者为30多岁,而女性患者年龄范围较广,从10岁到65岁。在估计的发病因素中,男性的发病因素往往与工作场所有关,而女性患者则表现出多种因素。84.0%的患者患有合并过敏性疾病。在症状严重程度和生活影响的10项指标中,只有1项发现男性和女性患者的QEESI评分存在显著差异。然而,在化学不耐受的所有10项指标中,女性均显著高于男性。我们研究中患者组的平均QEESI评分低于美国四个自我报告患者组中的任何一个。